📊 This is a company profile preview from Tablestat.com Request a Free Trial Now

Company profile: Symbiomix

1.1 - Company Overview

Symbiomix Logo

Symbiomix

Headquarter: United States
Founded: 20XX🔒
Employees: 100-500🔒

Company description

  • Provider of an anti-infective drug, a single-dose treatment, and innovative medicines for serious women's health infections that have long been neglected; a late-stage, privately held biopharmaceutical company.

Products and services

🔒

Key contacts

🔒
🔒

Financial details

🔒

1.2 - Competitors and similar companies to Symbiomix

RPS Diagnostics Logo

RPS Diagnostics

HQ: United States Website
  • Description: Provider of rapid point-of-care (POC) screening to identify patients with infectious diseases.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full RPS Diagnostics company profile →
Fio Logo

Fio

HQ: Canada Website
  • Description: Provider of a point-of-care medical device used to gather data through interactions with a healthcare system.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Fio company profile →
Eurocine Vaccines Logo

Eurocine Vaccines

HQ: United States Website
  • Description: Provider of nasal flu vaccines for children and the elderly, managing preclinical and clinical development, scalability into manufacturing, business development, and funding. Offers Endocine, a nasal vaccine adjuvant used in clinical trials showing safety and tolerability in over 400 human subjects; an HSV-2 therapeutic vaccine candidate; and vaccine development services from conceptualization to commercialization.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Eurocine Vaccines company profile →
DelSiTech Logo

DelSiTech

HQ: Finland Website
  • Description: Provider of biodegradable silica-based controlled-release drug delivery technologies and drug development services, focusing on parenteral and local administration. Offers Silica Matrix platform for small molecules, biopharmaceuticals, and viral vectors; long-acting injectables, ocular drug delivery, and supergeneric/505(b)(2) products such as DST1308 and DST2105.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full DelSiTech company profile →
Turn Therapeutics Logo

Turn Therapeutics

HQ: United States Website
  • Description: Provider of pharmaceutical solutions to reduce the human and economic costs of infection and skin disease, including PermaFusion petrolatum-based liquid-in-oil suspension technology for high-bioavailability delivery; Hexagen FDA-cleared antimicrobial wound dressing; a pre-operative nasal decolonization program targeting MRSA; and onychomycosis treatment.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Turn Therapeutics company profile →
🔒

2.M&A buyers

2.1 Potential strategic acquirers in the sector

🔒
🔒
🔒
🔒 View all strategic buyers with complete profiles
Start Free Trial →

2.2 - Strategic buyer groups for Symbiomix

🔒

Buyer group 1: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 2: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 3: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →

3. Investors and private equity firms

3.1 - Buyout funds investing in similar companies to Symbiomix

2.2 - Growth funds investing in similar companies to Symbiomix

🔒 View all growth equity funds with complete profiles
Start Free Trial →

4 - Top valuation comps for Symbiomix

4.2 - Public trading comparable groups for Symbiomix

🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →

4.3 - M&A Transactions similar to Symbiomix

Selected M&A transactions

Date Target Description Buyer(s) Relevance EV EV/Revenue EV/EBITDA
🔒 View all M&A transactions with complete deal terms
Request Free Trial Now →

Frequently Asked Questions

About Symbiomix

What does Symbiomix do?

Symbiomix is a provider of an anti-infective drug, a single-dose treatment, and innovative medicines for serious women's health infections that have long been neglected; a late-stage, privately held biopharmaceutical company.

Who are Symbiomix's competitors?

Symbiomix's competitors and similar companies include RPS Diagnostics, Fio, Eurocine Vaccines, DelSiTech, and Turn Therapeutics.

Where is Symbiomix headquartered?

Symbiomix is headquartered in United States.

How many employees does Symbiomix have?

Symbiomix has 1,000 employees 🔒.

When was Symbiomix founded?

Symbiomix was founded in 2010 🔒.

What sector and industry vertical is Symbiomix in?

Symbiomix is in the Enterprise Software 🔒 sector and industry

M&A Buyers & Acquirers for Symbiomix

Who are the top strategic acquirers in Symbiomix's sector and industry

Top strategic M&A buyers and acquirers in Symbiomix's sector include ████████, ██████████, ██████, ████████, and ██████████ 🔒.

Which M&A buyer groups are most relevant for Symbiomix?

Top strategic M&A buyers groups and sectors for Symbiomix include █████████████████ , ████████████████, █████████████, ████████████, and ████████████████ 🔒.

Financial Investors investing in Symbiomix's sector and industry vertical

Which are the top PE firms investing in Symbiomix's sector and industry vertical?

Top PE firms investing in Symbiomix's sector and industry vertical include ████████, ██████████, ████████, and ██████████ 🔒.

Who are the top buyout funds acquiring in Symbiomix's sector and industry vertical?

Active PE funds and buyout funds acquiring companies in Symbiomix's sector and industry vertical include █████████, ██████████, ████████████, and ████████████ 🔒.

Who are the top growth equity funds investing in companies in Symbiomix's sector and industry vertical?

Growth funds and venture capital funds investing in companies similar to Symbiomix include █████████, ██████████, ████████████, and ████████████ 🔒.

Valuation benchmarks of companies in Symbiomix's sector and industry

Which are the key public companies that are relevant trading comps benchmarks for Symbiomix?

The key public trading comparables and valuation benchmarks for Symbiomix include █████████, ██████████, ████████████, and ████████████ 🔒.

Which are the key trading comparable groups for Symbiomix for public valuation benchmarks?

Our platform tracks detailed public trading comparable groups and valuation benchmarks for Symbiomix with complete valuation multiples, growth metrics, and profitability data. Access the full database to benchmark your company against relevant public comparables.

What are recent M&A transactions in Symbiomix's sector and industry vertical?

Our platform tracks relevant M&A transactions comparables and valuation benchmarks for Symbiomix with complete deal terms, valuation multiples, and strategic rationale. Access the full database to benchmark pricing and identify active acquirers.

What are recent capital raises and funding rounds in Symbiomix's' sector and industry vertical?

Access recent funding rounds and capital raises in Symbiomix's sector and industry vertical including growth equity, venture capital, and buyout investments. Our database includes round size, lead investors and valuations.

Ready to Find the Right Buyers?

Access complete buyer lists, valuation data, and M&A intelligence for Symbiomix